3Irfan M,Hussain SF,Mapara K,et al.Community acquired pneumonia:risk factors associated with mortality in a tertiary care hospitalized patients[J].J Pak Med Assoc,2009,59(7):448-452.
4File TM.The science of selecting antimicrobials for community-acquired pneumonia (CAP)[J].J Manag Care Pharm,2009,15(2 Suppl):S5-11.
5Falguera M,Trujilano J,Caro S,et al.A prediction rule for estimating the risk of bacteremia in patients with community-acquired pneumonia[J].Clin Infect Dis,2009,49(3):409-416.
6Farah R,Makhoul N.Levels of fibrinogen compared to crp in plasma as new marker in diagnosis of pulmonary edema of non septic origin[J].Harefuah,2006,145(12):870-874,943-944.
2Piacentini E,Sánchez B,Arauzo V,et al.Procalcitonin levels are lower in intensive care unit patients with H1N1 influenza A virus pneumonia than in those with community-acquired bacterial pneumonia.A pilot study.J Crit Care,2011,26:201-205.
3Karhu J,Ala-Kokko TI,Ylipalosaari P,et al.Hospital and long-term outcomes of ICU-treated severe community-and hospital-acquired,and ventilator-associated pneumonia patients.Acta Anaesthesiol Scand,2011,55:1254-1260.
4Aydodu M,Ozyilmaz E,Aksoy H,et al.Mortality prediction in community-acquired pneumonia requiring mechanical ventilation;values of pneumonia and intensive care unit severity scores.Tuberk Toraks,2010,58:25-34.
